Publication of year-end report for the fiscal year 2023/2024
ODI Pharma AB (“ODI” or the “Company”) hereby publishes its year-end report for the period July 2023 – June 2024. The report is available...
top of page
News
We're thrilled to share the latest developments from our company.
Suche
ODI Pharma
25. Juni2 Min.
ODI Pharma AB announces strategic market entry with initial shipment to Switzerland
ODI Pharma AB (“ODI” or the “Company”) is pleased to announce the first delivery of cannabis products to the leading medical cannabis...
ODI Pharma
30. Mai4 Min.
ODI Pharma AB: Publication of interim report Q3 2023/2024
ODI Pharma AB (“ODI” or the “Company”) hereby publishes its interim report for the period July 2023 - March 2024. The report is available...
ODI Pharma
2. Mai2 Min.
Preliminary results for ODI Pharma indicate significant revenue increase in Q3 2023/2024
ODI Pharma AB (“ODI” or the “Company”) announces today that the preliminary financial results for the third quarter of fiscal year...
ODI Pharma
27. Feb.2 Min.
ODI Pharma AB: Updated market and business overview
ODI Pharma AB (“ODI” or the “Company”) hereby present an updated overview of its market position and the latest trends observed in the...
ODI Pharma
22. Feb.3 Min.
ODI Pharma AB: Publication of half-year report 2023/2024
ODI Pharma AB (“ODI” or the “Company”) hereby publishes its half-year report for the period July – December 2023. The report is available...
ODI Pharma
18. Jan.1 Min.
ODI Pharma AB anlitar Pareto Securities AB som likviditetsgarant
ODI Pharma AB (”ODI Pharma” eller ”Bolaget”) har idag utsett Pareto Securities till likviditetsgarant för Bolagets aktie som är upptagen...
ODI Pharma
18. Jan.2 Min.
ODI Pharma AB appoints Pareto Securities AB as liquidity provider
ODI Pharma AB (“ODI Pharma” or the “Company”) has today appointed Pareto Securities as the liquidity guarantor for the Company's shares,...
ODI Pharma
15. Dez. 20232 Min.
Announcement from the Annual General Meeting in ODI Pharma AB (publ)
This is an unofficial translation of a notice to the Annual General Meeting in ODI Pharma AB (publ), originally drafted in Swedish. In...
ODI Pharma
15. Dez. 20232 Min.
Kommuniké från årsstämma i ODI Pharma AB (publ)
Idag den 15 december 2023 hölls årsstämma i ODI Pharma AB (publ). Nedan följer en sammanfattning av de beslut som fattades. Samtliga...
ODI Pharma
6. Dez. 20233 Min.
ODI Pharma AB announces sale of the skincare brand kandol. for 3.2 msek
ODI Pharma AB (“ODI” or the “Company”) announces today the sale of the skincare brand kandol. to Niclas Kappelin. The transaction, valued...
ODI Pharma
27. Nov. 20232 Min.
Correction: ODI Pharma AB publishes the annual report for the fiscal year 2022/2023
The correction refers to the completion of the auditor's remark and ODI Pharma's comment which is now included in the press release. The...
ODI Pharma
27. Nov. 20232 Min.
Rättelse: ODI Pharma AB publicerar årsredovisning för räkenskapsåret 2022/2023
Rättelsen avser komplettering av revisorns anmärkning och ODI Pharmas kommentar som nu finns inkluderat i pressmeddelandet. Bifogad...
ODI Pharma
24. Nov. 20233 Min.
ODI Pharma AB: Publication of interim report report Q1 2023/2024
ODI Pharma AB (“ODI” or the “Company”) hereby publishes its interim report for the period July 2023 – September 2023. The report is...
ODI Pharma
24. Nov. 20231 Min.
ODI Pharma AB publishes the annual report for the fiscal year 2022/2023
The Board of Directors and the Chief Executive Officer of ODI Pharma AB (“ODI Pharma”) hereby publishes the annual report for the fiscal...
ODI Pharma
24. Nov. 20231 Min.
ODI Pharma AB publicerar årsredovisning för räkenskapsåret 2022/2023
Styrelsen och verkställande direktören för ODI Pharma AB (”ODI Pharma”) publicerar härmed årsredovisningen för räkenskapsåret 2022/2023....
ODI Pharma
23. Nov. 20231 Min.
ODI Pharma AB postpones publication of interim report and annual report until November 24, 2023
ODI Pharma AB (“ODI” or the “Company”) stated in its year-end report that the interim report for the first quarter of 2023/2024 and the...
ODI Pharma
13. Nov. 20235 Min.
Notice to Annual General Meeting in ODI Pharma AB (publ)
The shareholders of ODI Pharma AB (publ), 559223–1392, are hereby invited to attend the Annual General Meeting on Friday, 15th of...
ODI Pharma
13. Nov. 20234 Min.
Kallelse till årsstämma i ODI Pharma AB (publ)
Aktieägarna i ODI Pharma AB (publ), 559223–1392, kallas härmed till årsstämma fredagen den 15 december 2023 kl. 10.30 i bolagets lokaler...
ODI Pharma
24. Aug. 20234 Min.
ODI Pharma AB: Publication of year-end report for the fiscal year 2022/2023
ODI Pharma AB (“ODI” or the “Company”) hereby publishes its year-end report for the period July 2022 – June 2023. The report is available...
bottom of page